Bayer inks deals with eleven digital healthcare startups
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Bayer inks deals with eleven digital healthcare startups

10:17 AM, 11th October 2019
Bayer logo

BERLIN, GERMANY: Bayer has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients’ health in the fields of cardiovascular diseases, oncology, ophthalmology, pulmonology, radiology as well as digital therapeutics.

The participating healthcare startup companies were selected by Bayer from over 750 applications out of 65 countries based on the strategic fit, development stage of the project, and the assessment of internal experts.

The new program offers two different ways of collaboration with Bayer in the digital health space. Under the terms of the Growth Track, selected early-stage startups receive EUR 75.000 funding for co-creating products or solutions, as well as co-working space at Bayer’s Pharmaceuticals division headquarters in Berlin, Germany. Mentoring and coaching by Bayer executives are also part of the program. Under the terms of the Advance Track, startups looking to co-create and execute commercial deals are supported. Here, an initial project funding is followed by incremental milestone-based payments.

The digital health startups are Prevencio Med (US); Blackford Analysis (UK); NeuroTracker (Canada); Carepay (Kenya); RelianceHMO (Nigeria); OKKO Health (UK); Wellthy Theapeutics (India); Litesprite (USA); Visotec (Germany); BioLum Sciences (US) and Upside Health.

“We received a high number of very mature digital health startup applications and are excited to jointly develop and scale new digital solutions that will help benefit the health of our patients and consumers,” said Eugene Borukhovich, Head of Digital Health at Bayer.

“Our company’s “G4A Digital Health Partnerships” program paves the road for longer-term collaborations through which both parties can bring to market new solutions at the intersection of health and technology,” said Dr. Zsuzsanna Varga, who is heading the Bayer G4A Digital Health Partnerships program.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


BASF advances scientific research in Asia Pacific through 2020 grant

SINGAPORE: BASF is calling upon the research and academic community in Asia Pacific to submit research proposals to the Nutrition Asia Research Grant ...

Read more
Spain govt backs Montefibre Carbon's precursor fiber plant

MIRANDA DE EBRO, SPAIN: Montefibre Carbon, based in Spain has received € 5.6 million from the Spanish Ministry of Industry, Trade & Tourism a ...

Read more
Total wins exploration block in Brazil offshore bid

PARIS, FRANCE: Total, operator, and its co-venturers Qatar Petroleum and Petronas have won the C-M-541 deep offshore block on the 16th Bidding Ro ...

Read more
Merck expands and modernizes global pigments production

DARMSTADT, GERMANY: Merck KGaA said that it is significantly expanding its global production capacities and optimizing its manufacturing processes for ...

Read more
Bayer using AI to optimize drug discovery, disease diagnosis

LEVERKUSEN, GERMANY/READING, UK: Bayer has launched new LifeHub in UK. The hub will accelerate and optimize disease detection and data-driven drug dis ...

Read more
Nouryon introduces new range of demulsifiers for oilfield market

AMSTERDAM, NETHERLANDS: Nouryon has introduced new range of demulsifiers that provide oil producers with a more sustainable option to separate crude o ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X